Calcium sensitizing in sepsis: is levosimendan on the right path?
Morelli
Andrea
A
Ertmer
Christian
C
Westphal
Martin
M
D000818:Animals; D002118:Calcium / Q000097:blood*; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006835:Hydrazones / Q000008:administration & dosage*; D008833:Microcirculation / Q000187:drug effects*; D009061:Mouth Mucosa / Q000098:blood supply*; D009638:Norepinephrine / Q000008:administration & dosage*; D010100:Oxygen / Q000097:blood*; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D011724:Pyridazines / Q000008:administration & dosage*; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012772:Shock, Septic / Q000188:drug therapy*; D000077464:Simendan
D002316:Cardiotonic Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D000077464:Simendan; D010100:Oxygen; D002118:Calcium; D009638:Norepinephrine